Korea Exchange approves Baropharm's KOSDAQ listing; trading to start November 11
The Korea Exchange announced on November 9 that it had approved pharmacy-platform operator Baropharm's listing on KOSDAQ, with trading scheduled to begin November 11. Founded in 2019, Baropharm operates an integrated pharmacy platform. The company recorded consolidated revenue of 96.724 billion won and an operating loss of 3.932 billion won last year.